Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)

SHA:688050 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,504	1,404	947.42	575.86	431.2	272.62
Other Revenue	6.58	6.4	3.75	3.64	1.87	0.43
Revenue	1,511	1,410	951.18	579.5	433.07	273.05
Revenue Growth (YoY)	22.84%	48.24%	64.14%	33.81%	58.61%	39.88%
Cost of Revenue	542.93	479.83	230.04	88.35	68.08	43.97
Gross Profit	968.06	930.19	721.14	491.15	364.99	229.08
Selling, General & Admin	403.86	370.67	296.94	178.57	142.27	96.03
Research & Development	108.04	106.42	91.95	63.9	51.91	29.99
Other Operating Expenses	5.8	4.75	14.98	8.69	7.17	3.97
Operating Expenses	527.55	492.69	412.99	259.52	207.1	132.01
Operating Income	440.51	437.5	308.16	231.62	157.89	97.06
Interest Expense	-23.69	-20.73	-9.81	-2.02	-0.74	-
Interest & Investment Income	6.72	4.17	19.98	21.97	25.56	10.55
Currency Exchange Gain (Loss)	1.47	-0.46	0.62	-0.23	-0.92	0.42
Other Non Operating Income (Expenses)	-0.2	-0.29	0.03	-0.52	-0.15	-0.06
EBT Excluding Unusual Items	424.81	420.19	318.97	250.81	181.65	107.96
Gain (Loss) on Sale of Investments	-0.49	-0.69	-1.84	1.49	0.2	0.28
Gain (Loss) on Sale of Assets	-0.18	-0.08	0.11	0.01	0.02	-0.15
Asset Writedown	-1.98	-1.98	-	-	-	-
Other Unusual Items	13.94	13.65	10.43	11.77	5.9	2.95
Pretax Income	436.1	431.1	327.67	264.08	187.77	111.04
Income Tax Expense	41.31	44.02	41.62	36.85	20.01	14.92
Earnings From Continuing Operations	394.79	387.08	286.05	227.23	167.75	96.12
Minority Interest in Earnings	-1.12	1.32	17.93	5.46	3.59	0.44
Net Income	393.67	388.4	303.98	232.69	171.34	96.56
Net Income to Common	393.67	388.4	303.98	232.69	171.34	96.56
Net Income Growth	12.85%	27.77%	30.63%	35.80%	77.45%	44.80%
Shares Outstanding (Basic)	190	189	189	190	189	161
Shares Outstanding (Diluted)	190	189	190	190	189	161
Shares Change (YoY)	0.24%	-0.27%	0.25%	0.17%	17.57%	13.96%
EPS (Basic)	2.07	2.05	1.61	1.23	0.91	0.60
EPS (Diluted)	2.07	2.05	1.60	1.23	0.91	0.60
EPS Growth	12.58%	28.13%	30.31%	35.58%	50.93%	27.07%
Free Cash Flow	191.79	18.27	-157.72	-20.9	-91.92	4.62
Free Cash Flow Per Share	1.01	0.10	-0.83	-0.11	-0.49	0.03
Dividend Per Share	0.350	0.350	0.272	0.283	0.206	0.156
Dividend Growth	28.58%	28.58%	-3.92%	37.79%	32.13%	-
Gross Margin	64.07%	65.97%	75.82%	84.75%	84.28%	83.90%
Operating Margin	29.15%	31.03%	32.40%	39.97%	36.46%	35.55%
Profit Margin	26.05%	27.55%	31.96%	40.15%	39.56%	35.36%
Free Cash Flow Margin	12.69%	1.30%	-16.58%	-3.61%	-21.22%	1.69%
EBITDA	582.49	565.64	380.52	271.42	188.07	123.73
EBITDA Margin	38.55%	40.12%	40.01%	46.84%	43.43%	45.31%
D&A For EBITDA	141.98	128.14	72.36	39.79	30.18	26.67
EBIT	440.51	437.5	308.16	231.62	157.89	97.06
EBIT Margin	29.15%	31.03%	32.40%	39.97%	36.46%	35.55%
Effective Tax Rate	9.47%	10.21%	12.70%	13.95%	10.66%	13.44%
Revenue as Reported	1,511	1,410	951.18	579.5	433.07	273.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.